585 related articles for article (PubMed ID: 16857785)
21. A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis.
Vincan E; Brabletz T; Faux MC; Ramsay RG
Cells Tissues Organs; 2007; 185(1-3):20-8. PubMed ID: 17587804
[TBL] [Abstract][Full Text] [Related]
22. Silibinin reverses epithelial-to-mesenchymal transition in metastatic prostate cancer cells by targeting transcription factors.
Wu K; Zeng J; Li L; Fan J; Zhang D; Xue Y; Zhu G; Yang L; Wang X; He D
Oncol Rep; 2010 Jun; 23(6):1545-52. PubMed ID: 20428808
[TBL] [Abstract][Full Text] [Related]
23. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
[TBL] [Abstract][Full Text] [Related]
24. Epithelial-mesenchymal transition in gastric cancer (Review).
Katoh M
Int J Oncol; 2005 Dec; 27(6):1677-83. PubMed ID: 16273224
[TBL] [Abstract][Full Text] [Related]
25. Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression.
Usami Y; Satake S; Nakayama F; Matsumoto M; Ohnuma K; Komori T; Semba S; Ito A; Yokozaki H
J Pathol; 2008 Jul; 215(3):330-9. PubMed ID: 18491351
[TBL] [Abstract][Full Text] [Related]
26. Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells.
Tanaka S; Hosokawa M; Yonezawa T; Hayashi W; Ueda K; Iwakawa S
Biol Pharm Bull; 2015; 38(3):435-40. PubMed ID: 25757925
[TBL] [Abstract][Full Text] [Related]
27. [Epithelial-mesenchymal transition in cancer progression].
Gos M; Miłoszewska J; Przybyszewska M
Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
[TBL] [Abstract][Full Text] [Related]
28. EMT, the cytoskeleton, and cancer cell invasion.
Yilmaz M; Christofori G
Cancer Metastasis Rev; 2009 Jun; 28(1-2):15-33. PubMed ID: 19169796
[TBL] [Abstract][Full Text] [Related]
29. Epithelial-mesenchymal transition and colorectal cancer: gaining insights into tumor progression using LIM 1863 cells.
Bates RC; Pursell BM; Mercurio AM
Cells Tissues Organs; 2007; 185(1-3):29-39. PubMed ID: 17587805
[TBL] [Abstract][Full Text] [Related]
30. Frizzled-7 dictates three-dimensional organization of colorectal cancer cell carcinoids.
Vincan E; Darcy PK; Farrelly CA; Faux MC; Brabletz T; Ramsay RG
Oncogene; 2007 Apr; 26(16):2340-52. PubMed ID: 17016432
[TBL] [Abstract][Full Text] [Related]
31. Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact.
Tamiya S; Liu L; Kaplan HJ
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2755-63. PubMed ID: 20042656
[TBL] [Abstract][Full Text] [Related]
32. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
[TBL] [Abstract][Full Text] [Related]
33. [Over-expression of HIF-1alpha induces EMT of human prostate cancer cells].
Luo Y; He DL; Jiang YG; Li MC; Ning L; Shen SL
Zhonghua Nan Ke Xue; 2008 Sep; 14(9):800-4. PubMed ID: 18998463
[TBL] [Abstract][Full Text] [Related]
34. The Role of Cyanidin-3-
Kurter H; Basbinar Y; Ellidokuz H; Calibasi-Kocal G
Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004099
[TBL] [Abstract][Full Text] [Related]
35. Epithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cells.
Yan YR; Xie Q; Li F; Zhang Y; Ma JW; Xie SM; Li HY; Zhong XY
Neuropathology; 2014 Apr; 34(2):128-34. PubMed ID: 24112388
[TBL] [Abstract][Full Text] [Related]
36. Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of beta-catenin and E-cadherin.
Li LN; Zhang HD; Yuan SJ; Yang DX; Wang L; Sun ZX
Eur J Pharmacol; 2008 Jun; 588(1):1-8. PubMed ID: 18448095
[TBL] [Abstract][Full Text] [Related]
37. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
[TBL] [Abstract][Full Text] [Related]
38. The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis.
Bates RC; DeLeo MJ; Mercurio AM
Exp Cell Res; 2004 Oct; 299(2):315-24. PubMed ID: 15350531
[TBL] [Abstract][Full Text] [Related]
39. Fas signaling promotes motility and metastasis through epithelial-mesenchymal transition in gastrointestinal cancer.
Zheng HX; Cai YD; Wang YD; Cui XB; Xie TT; Li WJ; Peng L; Zhang Y; Wang ZQ; Wang J; Jiang B
Oncogene; 2013 Feb; 32(9):1183-92. PubMed ID: 22508480
[TBL] [Abstract][Full Text] [Related]
40. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
